Click here to read the Cover Story, "Digital imaging, AI advance investigation of systemic disease through the retina."
As a behavioral neurologist specializing in Alzheimer’s disease, I think retinal imaging biomarkers show great promise in aiding clinical diagnosis and as a marker of disease progression.
The retina is a noninvasively accessible outgrowth of the central nervous system that may demonstrate Alzheimer’s pathology either through changes in neuronal layer thickness, deposition of proteins such as amyloid, or alterations in the complexity of vascular connections.